Eli Lilly Picks Houston for $6.5 Billion API Manufacturing Facility

Eli Lilly announced it will build a $6.5 billion active pharmaceutical ingredient (API) manufacturing facility in Houston, Texas, specifically in Generation Park1 5.

The facility is part of Lilly's broader $27 billion manufacturing investment program and is the second of four planned major U.S. sites3.

The Houston plant will focus on domestic production of APIs for small molecule synthetic medicines1 4.

Manufacturing at this facility will support therapies in cardiometabolic, oncology, immunology, and neuroscience areas4.

This investment signals significant expansion and increased domestic pharmaceutical manufacturing capacity in the U.S.3 5.

Sources:

1. https://mlq.ai/news/eli-lilly-to-build-65-billion-manufacturing-facility-in-houston-texas/

3. https://pharmaphorum.com/news/lilly-names-houston-site-65bn-api-facility

4. https://www.fiercepharma.com/manufacturing/eli-lilly-picks-houston-site-build-65b-manufacturing-facility

5. https://www.bioprocessintl.com/facilities-capacity/texas-sized-investment-eli-lilly-announces-6-5bn-houston-manufacturing-facility

Sources:

Leave a Reply Cancel reply